ATE184612T1 - Peptidzusammensetzung aus pseudomonas und methode diese herzustellen - Google Patents

Peptidzusammensetzung aus pseudomonas und methode diese herzustellen

Info

Publication number
ATE184612T1
ATE184612T1 AT92901312T AT92901312T ATE184612T1 AT E184612 T1 ATE184612 T1 AT E184612T1 AT 92901312 T AT92901312 T AT 92901312T AT 92901312 T AT92901312 T AT 92901312T AT E184612 T1 ATE184612 T1 AT E184612T1
Authority
AT
Austria
Prior art keywords
peptide
reactive
cross
producing
pseudomonas
Prior art date
Application number
AT92901312T
Other languages
English (en)
Inventor
Robert S Hodges
William Paranchych
Randall T Irvin
Kok Kheong Lee
Sastry A Parimi
Dick Eric Zoutmon
Peter C Doig
Wah Yau Wong
Original Assignee
Synthetic Peptides Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthetic Peptides Inc filed Critical Synthetic Peptides Inc
Application granted granted Critical
Publication of ATE184612T1 publication Critical patent/ATE184612T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT92901312T 1991-01-04 1991-12-24 Peptidzusammensetzung aus pseudomonas und methode diese herzustellen ATE184612T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/638,492 US5494672A (en) 1989-04-28 1991-01-04 Pseudomonas peptide composition and method

Publications (1)

Publication Number Publication Date
ATE184612T1 true ATE184612T1 (de) 1999-10-15

Family

ID=24560266

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92901312T ATE184612T1 (de) 1991-01-04 1991-12-24 Peptidzusammensetzung aus pseudomonas und methode diese herzustellen

Country Status (8)

Country Link
US (1) US5494672A (de)
EP (1) EP0567470B1 (de)
JP (1) JPH06504528A (de)
AT (1) ATE184612T1 (de)
AU (1) AU661465B2 (de)
CA (1) CA2098296C (de)
DE (1) DE69131624T2 (de)
WO (1) WO1992012169A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340530C (en) * 1989-04-28 1999-05-04 Kok Kheong Lee Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
JPH0797395A (ja) * 1993-09-28 1995-04-11 Kyowa Medex Co Ltd ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途
US6872398B2 (en) * 1995-12-22 2005-03-29 The United States Of America As Represented By The Secretary Of The Army Conjugate vaccine against gram-negative bacterial infections
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
US6232287B1 (en) * 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
CA2329689A1 (en) 1998-06-12 1999-12-23 The Governors Of The University Of Alberta Composition and method for treatment of pseudomonas
US20030228324A1 (en) * 1999-05-06 2003-12-11 Malcolm Andrew J. Peptide compositions and methods of producing and using same
US7132101B2 (en) * 2002-02-27 2006-11-07 Duquesne University Of The Holy Ghost Compositions and methods for eliciting an immune response to gram-negative bacterial infections
AU2005294436A1 (en) * 2004-10-04 2006-04-20 Trinity Biosystems, Inc. Methods and compositions for immunizing against Pseudomonas infection
EP1919494A4 (de) * 2005-07-22 2011-11-09 Univ Colorado Regents Nichttoxischer biofolien-hemmer
MX2013007146A (es) * 2010-12-23 2013-11-01 Intercell Austria Ag Agentes de proteina f/i de membrana externa (oprf/i) y su uso en pacientes hospitalizados y otros pacientes.
US9408889B2 (en) * 2011-04-22 2016-08-09 Rutgers, The State University Of New Jersey Fusion peptide designed to reduce plaque bacteria and yeast in the oral cavity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886663A (en) * 1983-01-03 1989-12-12 Scripps Clinic And Research Foundation Synthetic heat-stable enterotoxin polypeptide of Escherichia coli and multimers thereof
US4745055A (en) * 1985-05-07 1988-05-17 California Biotechnology Inc. Fused protein for enzyme immunoassay system
AU616662B2 (en) * 1987-04-27 1991-11-07 Commonwealth Scientific And Industrial Research Organisation Peptide production by protein engineering
CA1340530C (en) * 1989-04-28 1999-05-04 Kok Kheong Lee Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
US5223604A (en) * 1991-06-25 1993-06-29 S.P.I. Synthetic Peptides Incorporated Pseudomonas exoenzyme s peptide composition and method

Also Published As

Publication number Publication date
EP0567470B1 (de) 1999-09-15
DE69131624D1 (de) 1999-10-21
CA2098296C (en) 1998-08-04
JPH06504528A (ja) 1994-05-26
AU661465B2 (en) 1995-07-27
CA2098296A1 (en) 1992-07-05
US5494672A (en) 1996-02-27
WO1992012169A1 (en) 1992-07-23
EP0567470A1 (de) 1993-11-03
AU9095991A (en) 1992-08-17
DE69131624T2 (de) 2000-05-31

Similar Documents

Publication Publication Date Title
US5686267A (en) Nucleic acid molecule encoding antigen associated with lyme disease
ATE184612T1 (de) Peptidzusammensetzung aus pseudomonas und methode diese herzustellen
Matsuda et al. Dissociation of tetanus neurotoxin into two polypeptide fragments
AU1974992A (en) Pseudomonas exoenzyme s peptide composition and method
Rose et al. Purification and chemical characterization of a cholera toxin-cross-reactive cytolytic enterotoxin produced by a human isolate of Aeromonas hydrophila
GB9108652D0 (en) Immunoreactive compounds
DE69129760D1 (de) T-cadherin-bindungsmolekül
Yamamoto et al. Application of monoclonal antibodies to the isolation and characterization of a killer toxin secreted by Hansenula mrakii
WO2005051998A3 (en) Antibodies binding to a c-terminal fragment of apolipoprotein e
ATE235916T1 (de) Verfahren zur herstellung von gegen e.coli bakterien der familie cs4-cfa/1 gerichteten antikörpern
CA2217522A1 (en) Isolated frpb nucleic acid molecule and vaccine
DE69104602D1 (de) Stressprotein aus bakterien.
WO2006041906A3 (en) Methods and compositions for immunizing against pseudomonas infection
EA201001190A1 (ru) Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков
Hamada et al. Cytokine production induced by a 67‐kDa fimbrial protein from Porphyromonas gingivalis
GB0309126D0 (en) Clostridium difficile focussed antibodies
DE69132813D1 (de) Genetisches igfbp-5 rodierendes material
NZ336781A (en) Fibronectin binding protein compositions, antibodies thereto, and methods of use
CA2316411A1 (en) Humanized monoclonal antibodies that protect against shiga toxin induced disease
NZ500151A (en) A general method for attaching DNA molecule comprising non-antibody target molecule (eg. CTLA-4 or L-selectin), antigen or epitope sequence, and optionally a polypeptide sequence
AU2032988A (en) A genus-specific listeria antigen identified by monoclonal antibodies
US20020081304A1 (en) Type f botulinum toxin and use thereof
CA2597701A1 (en) Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats o11 serotype
Shimazaki et al. Monoclonal antibody against bovine lactoferricin (R) and its epitopic site
CA2136239A1 (en) Leukotriene c4 synthase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties